GlassScriptPhysician profile
Karyn Morse Solky
NPI 1588728372
$2,722.77
in general payments reported to CMS, 2019-2025
25 companies · $715 in 2025
The $715 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $733 · 2020: $130 · 2021: $208 · 2022: $282 · 2023: $295 · 2024: $360 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $732.89 | 2019-2025 | Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $300.74 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $290.86 | 2019-2022 | |
| Exeltis, USA INC. | $214.35 | 2019-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $167.73 | 2019-2025 | |
| Sage Therapeutics, LLC | $131.20 | 2025 | Zurzuvae |
| Pfizer INC. | $124.59 | 2019-2025 | |
| Hologic Sales and Service, LLC | $103.95 | 2022-2024 | Aptima |
| Mayne Pharma Commercial LLC | $80.89 | 2023-2025 | |
| Coopersurgical, INC. | $80.41 | 2019-2025 | Onetrac Lx, Paragard T 380a |
| Evofem Biosciences, INC. | $61.74 | 2021-2025 | Solosec, Phexx, Phexxi |
| Sumitomo Pharma America, INC. | $51.32 | 2025 | Gemtesa |
| Myovant Sciences INC. | $49.80 | 2021-2022 | |
| Millicent US INC | $43.92 | 2025 | Intrarosa, Femlyv |
| Allergan, INC. | $43.36 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $37.59 | 2023-2024 | Twirla |
| Shield Therapeutics INC | $32.05 | 2023 | Accrufer |
| Baxter Healthcare | $30.95 | 2022 | |
| Exact Sciences Corporation | $24.09 | 2025 | Cologuard Collection Kit |
| Duchesnay USA Incorporated | $22.91 | 2019 | |
| Organon LLC | $22.17 | 2024 | |
| Avion Pharmaceuticals | $21.46 | 2022 | |
| Octapharma USA, INC. | $19.16 | 2025 | Fibryga |
| Supernus Pharmaceuticals, INC. | $18.21 | 2025 | Qelbree |
| Aspira Women'S Health INC | $16.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karyn Solky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.